Skip to content
Screener

CryoPort, Inc. CYRX Stock-Based Comp

Stock-Based Comp at other companies

Azenta logo
AzentaAZTA
$4.81M+47.5%
United Parcel Service, Inc. logo
United Parcel Service, Inc.UPS
$34M+780%
Cencora logo
CencoraCOR
$28.73M+23.9%
BioLife Solutions logo
BioLife SolutionsBLFS
$3.85M-34.2%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$83M+10.7%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$19.78M+16.0%

Other financials

Income statement

See full
Revenue$49.0M+7.7%
Gross profit$22.8M+6.8%
Operating income-$10.0M-4.0%
Net income-$8.3M-108%
EPS (diluted)-$0.20-109%

Balance sheet

See full
Cash & equivalents$269.3M+10.6%
Total debt$232.3M+423%
Total equity$490.7M-5.5%
Total assets$756.2M-2.3%

Cash flow

See full
Operating cash flow$1.1M+115%
CapEx$9.1M+109%
Free cash flow-$8.0M+31.8%

Valuation

See full
Market cap$750.62M+85.1%
Enterprise value$713.66M+245%
P/E
P/S+1.6×

Profitability

See full
Gross margin47.1%+0.8pp
Operating margin-21.2%-3.2pp
Net margin41.4%+23.4pp
FCF margin-10.7%-3.4pp

Returns & leverage

See full
Return on equity15.3%+9.1pp
Debt / equity0.5×+0.4×
Current ratio2.1×-14.2×

Where this comes from

Reported directly by CryoPort, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AllocatedShareBasedCompensationExpense.

The source filing: CryoPort, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-092107
Line itemSix Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Unrealized (gain) loss on investments in equity securities469(613)
Realized loss on available-for-sale investments1,4261,888
Gain on divested business(120,351)
Stock-based compensation expense4,7976,075
Loss on disposal of property and equipment64105
Change in credit losses(40)48
Excess and obsolete inventory36(36)
Change in contingent consideration48(5,206)

Cover / Front Matter

FAQ

What is CryoPort, Inc.'s stock-based comp?
CryoPort, Inc. (CYRX) reported stock-based comp of $2.4M in Q2 2026.
How has CryoPort, Inc.'s stock-based comp changed year-over-year?
CryoPort, Inc.'s stock-based comp increased by 1.1% year-over-year, from $2.38M to $2.4M.
What is the long-term trend for CryoPort, Inc.'s stock-based comp?
Over 4 years (2021 to 2025), CryoPort, Inc.'s stock-based comp has grown at a -7.9% compound annual growth rate (CAGR), from $15.35M to $11.03M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Ask your AI about CryoPort, Inc.'s stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude